Immunostep Overview

  • Founded
  • 2001
  • Status
  • Private
  • Employees
  • 16
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Immunostep General Information


Developer of mono and polyclonal antibodies intended to create market innovative products that improve the diagnostic and clinical research by flow cytometry. The company's antibodies are products that are mainly for flow cytometry in the oncology area, enabling researchers to improve the diagnostic and clinical research methodology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Avda. Universidad de Coimbra
  • S/N Centro de Investigación del Cáncer (C.I.C) Campus Miguel de Unamuno
  • 37007 Salamanca
  • Spain
+34 923 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Immunostep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 00.000 Completed Generating Revenue
6. Later Stage VC 25-May-2016 00.000 00.000 Completed Generating Revenue
5. Later Stage VC 27-Sep-2013 00000 00.000 Completed Generating Revenue
4. Grant 11-May-2010 000.00 00000 Completed Generating Revenue
3. Later Stage VC 27-Oct-2008 00000 00000 Completed Generating Revenue
2. Later Stage VC (Series B) 01-Jan-2007 Completed Generating Revenue
1. Early Stage VC 01-Jan-2004 Completed Startup
To view Immunostep’s complete valuation and funding history, request access »

Immunostep Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer of mono and polyclonal antibodies intended to create market innovative products that improve the diagnostic an
Salamanca, Spain
16 As of 2021
000000 - 000 00.000


eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
Irvine, CA
00 As of 0000
000000 - 000 00000


uip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum d
0000 000000000
Farmington, CT
0 As of 0000
0000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Immunostep Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
GeneTex Formerly VC-backed Irvine, CA 00 00000 000000 - 000 00000
0000000 Venture Capital-Backed Farmington, CT 0 00.000 0000000000 00.000
000000000000 Formerly VC-backed Beijing, China 000 00000 00000000 00000
00000000 Formerly VC-backed Sunnyvale, CA 0 00.000 00000000000 00.000
000000000 Corporation Farmingdale, NY 00 000000000 -
You’re viewing 5 of 22 competitors. Get the full list »

Immunostep Executive Team (5)

Name Title Board Seat Contact Info
Ricardo Acevedo Co-Founder & Chief Executive Officer
Ángeles Cabero García Chief Financial Officer
Alfredo Conde Alonso Co-Founder & Production Director
José Parra Co-Founder & Service and Purchasing Director
You’re viewing 4 of 5 executive team members. Get the full list »

Immunostep Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Immunostep Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alentia Capital Alternativo Other Minority 000 0000 000000 0
Castilla y León Corporation 000 0000 000000 0
Sodical Instituto Financiero de Castilla y León Venture Capital Minority 000 0000 000000 0
To view Immunostep’s complete investors history, request access »